No | Primary DI | Version or Model | Catalog Number | Device Description | Product Code | Product Code Name | Device Class | Brand Name |
---|---|---|---|---|---|---|---|---|
1 | 00812747010057 | 4.x.x | NextGen version 4.x.x | MMH | SOFTWARE, BLOOD BANK, STAND ALONE PRODUCTS | 2 | NextGen | |
2 | 10812747018159 | 01-097 | PIPETTE KIT, 1000UL | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | 2 | TEG5000 | |
3 | 30812747013875 | 08150-110-E | MCS+ (RBC), LIST NO 08150-110-E | GKT | Separator, automated, blood cell, diagnostic | 2 | MCS+ | |
4 | 30812747018184 | 07-022 | TEG ANALYZER, 5000, 120V, 60HZ, FG | JPA | SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES | 2 | TEG5000 HEMOSTASIS ANALYZER | |
5 | 00812747010101 | 3.x.x | SafeTrace Tx version 3.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | SafeTrace Tx | |
6 | 00812747010033 | 4.x.x | SafeTrace Tx version 4.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | SafeTrace Tx | |
7 | 30812747013851 | 08150-220-E | MCS+ (RBC), LIST NO 08150-220-E | GKT | Separator, automated, blood cell, diagnostic | 2 | MCS+ | |
8 | 30812747011673 | 0694S-00 | Plasma Bottles with Saline Adapter | KSR | CONTAINER, EMPTY, FOR COLLECTION & PROCESSING OF BLOOD & BLOOD COMPONENTS | Haemonetics® PCS®2 & NexSys PCS™ Systems | ||
9 | 20887691002872 | 732-37M | Transfer Bag 1000 ml w/Y Set | KSR | CONTAINER, EMPTY, FOR COLLECTION & PROCESSING OF BLOOD & BLOOD COMPONENTS | 2 | Haemonetics Corporation | |
10 | 10887691304214 | BPFBLA | Leukotrap High Efficiency Leukocyte Reduction Filtration System for Red Blood Ce Leukotrap High Efficiency Leukocyte Reduction Filtration System for Red Blood Cells with BPF4 Filter | CAK | Microfilter, blood transfusion | 2 | Haemonetics Leukotrap SC RC | |
11 | 10887691000581 | RCXL1K | RCXL1 High Efficiency Leukocyte Redution Filter with Attached Straight Administr RCXL1 High Efficiency Leukocyte Redution Filter with Attached Straight Administration Set for Single Unit Blood Transfusion | CAK | Microfilter, blood transfusion | 2 | RCXL1 | |
12 | 10812747016278 | 0265F-00 | CS5/5+ FASTPACK, 125ML 20µ RES | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER 5/5+ SYSTEM | |
13 | 10812747016261 | 0260F-00 | CS5/5+ FASTPACK,225ML, 20µ RES | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER 5/5+ SYSTEM | |
14 | 10812747015172 | 0291A-00 | CELL SAVER 5/5+ BOWL SET (70ML) | CAC | Apparatus, Autotransfusion | HAEMONETICS CELL SAVER 5/5+ SYSTEM | ||
15 | 10812747015165 | 0263A-00 | HIGH SPEED CELL SAVER5/5+BOWL SET | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER 5/5+ SYSTEM | |
16 | 10812747012492 | 09082-00 | TPE PROTOCOL/MANUAL,LN09082-00 | GKT | Separator, automated, blood cell, diagnostic | 2 | MCS+ | |
17 | 10812747012485 | 09081-00 | SDP/PLP PROT MANUL,LN 09081-00 | GKT | Separator, automated, blood cell, diagnostic | 2 | MCS+ | |
18 | 10812747011761 | 00620-CP | PLS Harness Set | GKT | Separator, automated, blood cell, diagnostic | 2 | Haemonetics® PCS®2 & NexSys PCS™ Systems | |
19 | 10812747011754 | 00620-00 | PLS Harness Set | GKT | Separator, automated, blood cell, diagnostic | 2 | Haemonetics® PCS®2 & NexSys PCS™ Systems | |
20 | 10812747011730 | 00695-00 | PLS Saline Adaptor | GKT | Separator, automated, blood cell, diagnostic | 2 | Haemonetics® PCS®2 & NexSys PCS™ Systems | |
21 | 30812747019228 | 0697S-00 | Persona™ Plasma Pooling Bottles | KSR | CONTAINER, EMPTY, FOR COLLECTION & PROCESSING OF BLOOD & BLOOD COMPONENTS | 2 | Haemonetics® NexSys PCS® System | |
22 | 30812747016616 | CSE-E-US | CELL SAVER ELITE | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
23 | 00812747010187 | 4.x.x | NexLynk DMS version 4.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | NexLynk DMS | |
24 | 00812747010149 | 3.x.x | ElDorado Donor version 3.x.x | MMH | SOFTWARE, BLOOD BANK, STAND ALONE PRODUCTS | 2 | ElDorado Donor | |
25 | 00812747010132 | 2.x.x | ElDorado Donor 2.x.x | MMH | SOFTWARE, BLOOD BANK, STAND ALONE PRODUCTS | 2 | ElDorado Donor | |
26 | 20812747016220 | 00401-00 | EXTENSION LINES | FRN | Pump, Infusion | HAEMONETICS R.I.S. SYSTEM | ||
27 | 10812747016636 | CSE-FP-225F | CS ELITE FASTPACK, 225ML, 20µ | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
28 | 10812747016582 | CSE-FP-225V | CS ELITE FASTPACK,225ML,150µ | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
29 | 10812747016575 | CSE-FP-125V | CS ELITE FASTPACK,125ML,150µ | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
30 | 10812747016568 | CSE-B-1000 | WASTE BAG, 10L | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
31 | 10812747016551 | CSE-SQ-1000 | SEQUESTRATION KIT | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
32 | 10812747016544 | CSE-P-225 | CS ELITE PROCESSING KIT (225ML) | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
33 | 10812747016537 | CSE-P-125 | CS ELITE PROCESSING KIT (125ML) | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
34 | 10812747016520 | CSE-P-70 | CS ELITE PROCESSING KIT (70ML) | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER ELITE SYSTEM | |
35 | 30812747017910 | OPA-E-US | ORTHOPAT ADVANCE, LN OPA-E-US | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS ORTHOPAT ADVANCE SYSTEM | |
36 | 30812747016814 | 02005-110-EP | CS5+,110V ENG, LN02005-110-EP | CAC | Apparatus, Autotransfusion | 2 | HAEMONETICS CELL SAVER 5+ SYSTEM | |
37 | 00812747010200 | 3.x.x | Donor Doc version 3.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | Donor Doc | |
38 | 00812747010194 | 3.x.x | Symphony version 3.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | Symphony | |
39 | 00812747010064 | 1.x.x | CDCS version 1.x.x | MMH | Blood Establishment Computer Software and Accessories | 2 | CDCS (Cross Donation Check System) | |
40 | 30812747012878 | 09000-220-EW | MCS+, 220V, LN09000-220-EW-RU | GKT | Separator, automated, blood cell, diagnostic | 2 | HAEMONETICS MCS+ (LN9000) APHERESIS SYSTEM | |
41 | 30812747012854 | 09000-220-E | MCS+, 220V ENGL, LN 09000-220-E | GKT | Separator, automated, blood cell, diagnostic | 2 | HAEMONETICS MCS+ (LN9000) APHERESIS SYSTEM | |
42 | 30812747012816 | 09000-110-E | MCS+ ,110V ENGL, LN 09000-110-E | GKT | Separator, automated, blood cell, diagnostic | 2 | HAEMONETICS MCS+ (LN9000) APHERESIS SYSTEM | |
43 | 20887691308745 | 430-40 | Leukocyte Reduction Filter System for Red Blood Cells with BPF4 High Efficiency Leukocyte Reduction Filter System for Red Blood Cells with BPF4 High Efficiency Filter, 16-Segment Tubing, Storage Bag and Sample Pouch | CAK | Microfilter, blood transfusion | 2 | Leukocyte SC RC | |
44 | 10887691001243 | SB1E | LipiGuard SB Reinfusion Filter for Salvaged Blood | CAK | Microfilter, blood transfusion | 2 | LipiGuard SB | |
45 | 10887691000550 | PXL8Y | PXL 8 High Efficiency Leukocyte Reduction Filter for Platelets with Attached Y-T PXL 8 High Efficiency Leukocyte Reduction Filter for Platelets with Attached Y-Type Administration Set | CAK | Microfilter, blood transfusion | 2 | PXL 8 | |
46 | 10887691000536 | PXL8C | PXL 8 High Efficiency Leukocyte Reduction Filter for Platelets with Attached Extension Set | CAK | Microfilter, blood transfusion | 2 | PXL 8 | |
47 | 10887691000505 | PXL12K | PXL 12 High Efficiency Leukocyte Reduction Filter with Attached Straight Adminis PXL 12 High Efficiency Leukocyte Reduction Filter with Attached Straight Administration Set | CAK | Microfilter, blood transfusion | 2 | PXL 12 High Efficiency Leukocyte Reduction Filter | |
48 | 10812747018074 | 07-016 | PLATELETMAPPING ASSAY AA | JOZ | SYSTEM, AUTOMATED PLATELET AGGREGATION | 2 | TEG HEMOSTASIS SYSTEM | |
49 | 10812747018067 | 07-015 | PLATELETMAPPING ASSAY ADP | JOZ | SYSTEM, AUTOMATED PLATELET AGGREGATION | 2 | TEG HEMOSTASIS SYSTEM | |
50 | 10812747018050 | 07-014 | PLATELETMAPPING ASSAY ADP & AA | JOZ | SYSTEM, AUTOMATED PLATELET AGGREGATION | 2 | TEG HEMOSTASIS SYSTEM |
No | Primary DI | Version or Model | Catalog Number | Device Description | Brand Name | Organization Name |
---|---|---|---|---|---|---|
1 | 05391521421081 | M01000 | Destiny MAX Analyzer | TCOAG IRELAND LIMITED | ||
2 | 05391521421029 | H01000P | Destiny Plus | TCOAG IRELAND LIMITED | ||
3 | 05391521421012 | N04000 | KC® 4 Delta | TCOAG IRELAND LIMITED | ||
4 | 05391521421005 | G05000 | KC® 1 Delta | TCOAG IRELAND LIMITED | ||
5 | 04987562433735 | BV981798 | CS-2500 COMPLETE | Automated Blood Coagulation Analyzer CS-2500 | SYSMEX CORPORATION | |
6 | 04987562425686 | BR142626 | Automated Blood Coagulation Analyzer CA-620 | Automated Blood Coagulation Analyzer CA-600 series CA-620 | SYSMEX CORPORATION | |
7 | 04987562425426 | BY990757 | CS-5100 COMPLETE | Automated Blood Coagulation Analyzer CS-5100 | SYSMEX CORPORATION | |
8 | 04987562409471 | 06372511 | CS-2100i COMPLETE | Automated Blood Coagulation Analyzer CS-2100i | SYSMEX CORPORATION | |
9 | G0561025161 | 102516 | 102516 | Lupus Anticoagulant Confirmation Reagent | BIO/DATA CORPORATION | |
10 | 04260160470587 | delta System (US/CA) | 201001 | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. | ROTEM® | TEM INNOVATIONS GMBH |
11 | 04260160470372 | sigma | 211000 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | ROTEM® | TEM INNOVATIONS GMBH |
12 | 04260160470358 | sigma ROTROL P | 555202 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | ROTEM® | TEM INNOVATIONS GMBH |
13 | 04260160470341 | sigma ROTROL N | 555201 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | ROTEM® | TEM INNOVATIONS GMBH |
14 | 04260160470327 | sigma complete + hep | 555502 | The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system in The ROTEM sigma is an in vitro diagnostic (IVD) whole blood hemostasis system intended for use in the evaluation of coagulopathies in Point of Care (POC) or laboratory settings. It uses rotational thromboelastometry to provide semiquantitative information about the coagulation state of a blood sample. The ROTEM sigma system records the kinetic changes in a sample of 3.2% citrated whole blood during clot formation, as well as when the sample clot retracts and/or lyses.Several parameters are measured and reported for this purpose. The graphical presentation reflects the various physiological results, which describe the interaction between coagulation factors and inhibitors, fibrinogen, platelets, and the fibrinolysis system. Additionally, the effect of certain drugs influencing hemostasis, in particular some anticoagulants (e.g. heparin), can be detected. | ROTEM® | TEM INNOVATIONS GMBH |
15 | 04260160470242 | ex-tem® | 503-05-US | The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor The EXTEM assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the extrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). | ROTEM® | TEM INNOVATIONS GMBH |
16 | 04260160470112 | ROTROL P | 503-25-US, 503-25 | ROTROL P is a quality control material for monitoring accuracy and precision of ROTROL P is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. | ROTEM® | TEM INNOVATIONS GMBH |
17 | 04260160470105 | ROTROL N | 503-24-US, 503-24 | ROTROL N is a quality control material for monitoring accuracy and precision of ROTROL N is a quality control material for monitoring accuracy and precision of tests carried out on the ROTEM® delta Thromboelastometry System. For in vitro diagnostic use only. | ROTEM® | TEM INNOVATIONS GMBH |
18 | 04260160470099 | star-tem® 20 | 503-10-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve – clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The star-tem® reagent is intended for use as recalcification reagent in the NATEM and INTEM assay on the ROTEM® delta. The corresponding assays are described in the NATEM assay application sheet and in the Instructions for Use of the in-tem® reagent (REF 503-02-US), resp. | ROTEM® | TEM INNOVATIONS GMBH |
19 | 04260160470082 | hep-tem® | 503-09-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environ-ment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The hep-tem® assay is a semi-quantitative in vitro diagnostic assay used to inactivate heparin in patients receiving unfractionated heparin on the ROTEM® delta. To monitor the coagulation process citrated whole blood specimens are used. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). | ROTEM® | TEM INNOVATIONS GMBH |
20 | 04260160470075 | fib-tem® | 503-06-US | The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® The FIBTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking platelet contribution to the clot firmness. fib-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameter Clot Firmness (A20/MCF). | ROTEM® | TEM INNOVATIONS GMBH |
21 | 04260160470068 | ap-tem® | 503-04-US | The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® d The APTEM assay is a semi-quantitative in vitro diagnostic assay on the ROTEM® delta Thromboelastometry System to monitor the clot firmness of citrated whole blood specimens after blocking hyperfibrinolysis by aprotinin. ap-tem® is always used in conjunction with ex-tem®. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). CFT and alpha (Speed of Clot Formation) are complementary parameters and should be used in conjunction with the main parameters Clotting Time (CT) and Clot Firmness (A20/MCF). | ROTEM® | TEM INNOVATIONS GMBH |
22 | 04260160470044 | in-tem® | 503-02-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively.The in-tem® assay is a semi-quantitative in vitro diagnostic assay used to monitor the coagulation process via the intrinsic pathway in citrated whole blood specimens on the ROTEM® delta. Clotting characteristics are described by the functional parameters Clotting Time (CT), Speed of Clot Formation (CFT and alpha angle), Clot Firmness (A20/MCF) and Clot Lysis (LOT, ML, LI(x)). | ROTEM® | TEM INNOVATIONS GMBH |
23 | 04260160470020 | delta System | 200100-US | The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a l The ROTEM® delta is designed for in-vitro diagnostic use by professionals in a laboratory environment. The ROTEM® delta is intended to be used to provide a qualitative and quantitative indication of the coagulation state of a blood sample. For this purpose the ROTEM® delta records the clot firmness changes in a sample of citrated whole blood as the sample clots, retracts and lyses in real time. The analyzer output consists of a qualitative graphical representation (mirrored coagulation curve - clot firmness over time) and several defined numerical parameters describing the curve quantitatively. | ROTEM® | TEM INNOVATIONS GMBH |
24 | 03607450590272 | 59027 | STA R Max® (with cap piercing option) | DIAGNOSTICA STAGO | ||
25 | 03607450590265 | 59026 | STA R Max® | DIAGNOSTICA STAGO | ||
26 | 03607450590135 | 59013 | STA R Max® | DIAGNOSTICA STAGO | ||
27 | 03607450590104 | 59010 | STA R Max® (with cap piercing option) | DIAGNOSTICA STAGO | ||
28 | 03607450589900 | 58990 | STA Compact Max® | DIAGNOSTICA STAGO | ||
29 | 03607450589894 | 58989 | STA Compact Max® (with cap piercing option) | DIAGNOSTICA STAGO | ||
30 | 03607450589795 | 58979 | STA-R Evolution® Expert Series (with cap piercing option) | DIAGNOSTICA STAGO | ||
31 | 03607450589788 | 58978 | STA-R Evolution® Expert Series | DIAGNOSTICA STAGO | ||
32 | 03607450581041 | 58104 | STA Satellite® | DIAGNOSTICA STAGO | ||
33 | 00842768026812 | 10487098 | ORKL19 | Standard Human Plasma for the calibration of coagulation and fibrinolysis tests | Standard Human Plasma | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
34 | 00842768024887 | 10458677 | OVKF032 | The BFT II Analyzer is a semi-automated device intended for use to determine PT, The BFT II Analyzer is a semi-automated device intended for use to determine PT, APTT and Fibrinogen | BFT II Analyzer | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
35 | 00842768017742 | 10446684 | OWZC39 | Washing Solution is used for cleaning the Siemens Healthcare Diagnostics coagula Washing Solution is used for cleaning the Siemens Healthcare Diagnostics coagulation analyzers | Washing Solution for Coagulation Analyzers | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
36 | 00842768014222 | 10446232 | ORHO37 | Supplementary Reagent for coagulation tests | Calcium Chloride Solution | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
37 | 00842768012358 | 10446541 | OVMN11 | The cuvettes serve coagulation tests as a reaction vessel. | Cuvettes for BFT // Analyzer | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
38 | 00842768012259 | 10446530 | OVKG03 | The cuvettes serve coagulation tests as a reaction vessel. | BFT II Analyzer Dispo System | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
39 | 00842768006869 | 10445989 | OPCC03 | For calibration of the Berichrom Heparin assay for measurement of unfractionated heparin | Berichrom® Heparin UF Calibrator | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
40 | 00842768006845 | 10445987 | OPCA03 | For calibration of the Berichrom Heparin assay for measurement of low molecular For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin | Berichrom® Heparin LMW Calibrator | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH |
41 | 00817869020311 | SC-125, SC-126, H2O | Hemotec Whole Blood Control Kit Large | ANALYTICAL CONTROL SYSTEMS INC | ||
42 | 00817869020274 | SC-127 | SC-127 | Whole Blood Control Level III | ANALYTICAL CONTROL SYSTEMS INC | |
43 | 00817869020267 | SC-126 | SC-126 | Whole Blood Control Level II | ANALYTICAL CONTROL SYSTEMS INC | |
44 | 00817869020250 | SC-125 | SC-125 | Whole Blood Control Level I | ANALYTICAL CONTROL SYSTEMS INC | |
45 | 00817869020007 | CR-109 | CR-109 | .02M Calcium Chloride | ANALYTICAL CONTROL SYSTEMS INC | |
46 | 00673978519173 | 550-90 | CONTROL TEST 550-90 PROFICIENCY 5L | NA | MEDTRONIC, INC. | |
47 | 00613994615633 | 313-51 | DEVICE 313-51 HEPTRAC ELEC QLT CNTRL CEM | HEPtrac® | MEDTRONIC, INC. | |
48 | B55890013181 | 900-1318 | 900-1318 | The Reference Plasma Quality Control Kit is for use with the Sonoclot® Analyzer The Reference Plasma Quality Control Kit is for use with the Sonoclot® Analyzer System to verify performance of activated cuvettes. Testing should be performed prior to the use of a new shipment of activated cuvettes and monthly throughout use of the stock. More frequent testing may be required to comply with local, state and federal QC requirements. Reference plasma quality control is important to properly verify proper performance of coagulation test activators. A two level testing approach is used to perform quality control of the activator used in an activated coagulation test. Level I is run with the activator on the reference plasma. Level II is run with the non-activated test on the reference plasma. These two tests confirm the effectiveness of the activator to perform its intended coagulation activation.Each Kit contains:1 vial Reference Plasma Control - 6 ml vial containing a lyophilized preparation of citrated animal plasma, stabilizers and buffer. Contains no human material.1 vial Distilled Water - 6 ml vial containing 5.0 ml laboratory grade distilled water.1 vial 0.02 M Calcium Chloride - 6 ml vial containing 5.0 ml 0.02 M Calcium Chloride.5 plastic 1 ml syringes2 non-activated test cuvettes (blue with clear caps, stir bars, and probes) | Sonoclot® Reference Plasma Quality Control Kit | SIENCO, INC. |
49 | B55890013021 | 900-1302 | 900-1302 | The Reference Viscosity Oil QC test is a simple means of verifying proper operat The Reference Viscosity Oil QC test is a simple means of verifying proper operation of the Sonoclot Analyzer. This test consists of a two point verification of the electromechanical oscillator and also ensures that the heating control is operating accurately. The two verification points are: 1) Probe-In-Air, and 2) Probe-In-Oil. The Probe-In-Air is the response of the electromechanical oscillator to air. The Probe-In-Oil is the response of the electromechanical oscillator to the reference viscosity liquid. Since the viscosity of the reference viscosity fluid is significantly temperature dependent, the Probe-In-Oil test point also verifies the temperature regulation. The QC test should be run each day the Sonoclot Analyzer is used or as required by your institution. Each Reference Viscosity Quality Control Kit contains 24 cuvettes, 24 probes, 1 vial of reference viscosity oil with end cap, and these instructions. These supplies provide 24 QC tests for the analyzer. | Sonoclot® Reference Viscosity Oil Quality Control Kit | SIENCO, INC. |
50 | B55880004321 | 800-0432 | 800-0432 | The SonACT Kit is an in vitro diagnostic reagent for use with the Sonoclot® Coag The SonACT Kit is an in vitro diagnostic reagent for use with the Sonoclot® Coagulation & Platelet Function Analyzer System. The SonACT test is a celite activated whole blood clotting time test. It may also be used with citrated whole blood and plasma. The SonACT Kit is intended for general purpose global hemostasis monitoring including: clot detection, fibrin formation, platelet function, and hyperfibrinolysis. The monitoring information is typically used for anticoagulant management up to high heparin levels (0 to approximately 6 units per ml), hypercoagulable and/or hypocoagulable screening, platelet function assessment, and hyperfibrinolysis screening. When used with the Sonoclot Analyzer System, the SonACT test provides quantitative Onset/ACT and Clot Rate results as well as qualitative and quantitative information on the Sonoclot Signature including: fibrin formation, platelet function, and hyperfibrinolysis.Each kit contains 100 lidded colorless plastic activation cuvettes, 100 probes, and instructions for use. The activation cuvettes contain a controlled amount of celite and a magnetic stir bar. | Sonoclot® SonACT Kit | SIENCO, INC. |